Emergent BioSolutions has acquired Cangene Corporation. Emergent BioSolutions is a global specialty biopharmaceutical company seeking to protect and enhance life by offering specialized products to healthcare providers and governments to address medical needs and emerging health threats. Emergent's mission is simple - to protect and enhance life.
View Top Employees from Cangene CorporationWebsite | https://www.emergentbiosolutions.com |
Revenue | $127 million |
Employees | 71 (13 on RocketReach) |
Founded | 1998 |
Phone | (410) 843-5000 |
Fax | (204) 269-7003 |
Industry | Biotechnology, Healthcare, Pharmaceuticals, Drug Manufacturing & Research |
Competitors | ADMA Biologics, Inc., Alpha Therapeutic Corporation, Aptevo Therapeutics Inc, Grifols SA, Plasvacc Australia |
SIC | SIC Code 283 Companies, SIC Code 28 Companies |
NAICS | NAICS Code 32541 Companies, NAICS Code 325 Companies, NAICS Code 3254 Companies, NAICS Code 541 Companies, NAICS Code 5417 Companies, NAICS Code 32 Companies, NAICS Code 54 Companies |
Looking for a particular Cangene Corporation employee's phone or email?
The Cangene Corporation annual revenue was $127 million in 2023.
13 people are employed at Cangene Corporation.
Cangene Corporation is based in Rockville, Maryland.
The NAICS codes for Cangene Corporation are [32541, 325, 3254, 541, 5417, 32, 54].
The SIC codes for Cangene Corporation are [283, 28].